Abattis Bioceuticals Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
ATTBF has 476.05 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 476.05M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | 0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 0.00 |
| P/OCF Ratio | 0.00 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.73, with a Debt / Equity ratio of 0.01.
| Current Ratio | 0.73 |
| Quick Ratio | 0.52 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.02 |
| Interest Coverage | -92.52 |
Financial Efficiency
Return on equity (ROE) is -28.13% and return on invested capital (ROIC) is -22.30%.
| Return on Equity (ROE) | -28.13% |
| Return on Assets (ROA) | -15.94% |
| Return on Invested Capital (ROIC) | -22.30% |
| Return on Capital Employed (ROCE) | -27.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.77 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -56.88 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 48.15 |
| Average Volume (20 Days) | 10,197 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.29 |
Income Statement
In the last 12 months, ATTBF had revenue of 269,576 and -2.30 million in losses. Loss per share was -0.00.
| Revenue | 269,576 |
| Gross Profit | 182,300 |
| Operating Income | -2.95M |
| Pretax Income | -2.31M |
| Net Income | -2.30M |
| EBITDA | -2.90M |
| EBIT | -2.95M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 1.81 million in cash and 113,956 in debt, giving a net cash position of 1.70 million or 0.00 per share.
| Cash & Cash Equivalents | 1.81M |
| Total Debt | 113,956 |
| Net Cash | 1.70M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 8.06M |
| Book Value Per Share | 0.02 |
| Working Capital | -989,820 |
Cash Flow
In the last 12 months, operating cash flow was 7.11 million and capital expenditures -45,925, giving a free cash flow of 7.06 million.
| Operating Cash Flow | 7.11M |
| Capital Expenditures | -45,925 |
| Free Cash Flow | 7.06M |
| FCF Per Share | 0.01 |
Margins
| Gross Margin | 67.62% |
| Operating Margin | -1,095.65% |
| Pretax Margin | -857.72% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 2,620.32% |
Dividends & Yields
ATTBF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -45.83% |
| Shareholder Yield | -45.83% |
| Earnings Yield | -482,744.75% |
| FCF Yield | 1,483,982.56% |
Stock Splits
The last stock split was on September 11, 2012. It was a reverse split with a ratio of 0.2.
| Last Split Date | Sep 11, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
ATTBF has an Altman Z-Score of -5.99. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.99 |
| Piotroski F-Score | n/a |